Skip to main content
Premium Trial:

Request an Annual Quote

John Niederhuber, Judy Garber, Geoffrey Ginsburg, Giovanni Parmigiani, David Rimm, Howard Scher

Konica Minolta Precision Medicine has announced the formation of its scientific advisory board, which include John Niederhuber, Judy Garber, Geoffrey Ginsburg, Giovanni Parmigiani, David Rimm, and Howard Scher. John Niederhuber has also been appointed as the board's chairman.

Niederhuber is currently CEO of the Genomics and Bioinformatics Research Institute, and formerly served as the director of the National Cancer Institute  and the National Institutes of Health.

Garber is currently chief of the division of cancer genetics and prevention at the Dana-Farber Cancer Institute, as well as a professor at Harvard Medical School.

Ginsburg currently serves as the founding director at the center for applied genomics & precision medicine at the Duke University Medical Center.

Parmigiani is currently associate director for population sciences of the multi-institutional Dana-Farber/Harvard Cancer Center, as well as director of the postdoctoral training grant in quantitative sciences for Cancer research at the Harvard T.H. Chan School of Public Health.

Rimm currently serves as professor of pathology and medicine at the Yale University School of Medicine, as well as the director of Yale Pathology Tissue Services.

Scher acts as the co-chair for mechanism based therapy and head of the biomarker development initiative at Memorial Sloan Kettering Cancer Center.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.